Weight loss drugs up abdominal paralysis risk: Study | India News
India News: A new US study suggests that weight-loss medications like Wegovy and Ozempic may have rare but serious side effects, including abdominal paralysis, li
Stay updated with breaking news from Disease Week. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
India News: A new US study suggests that weight-loss medications like Wegovy and Ozempic may have rare but serious side effects, including abdominal paralysis, li
Biodexa Pharmaceuticals PLC announced that results of a Phase 2 clinical trial of eRapa in Familial Adenomatous Polyposis are scheduled for presentation at the prestigious 2024 Digestive Disease...
Dual-acting IL-23 inhibitor tops placebo, ustekinumab in phase III trials
/PRNewswire/ -- SonarMD today presented positive results from two large, longitudinal studies evaluating several major drivers of medical costs in people...
First-in-human study targets ghrelin production with mucosal ablation as obesity treatment